Patterns of health care utilization related to initiation of amitriptyline, duloxetine, gabapentin, or pregabalin in fibromyalgia

por Kim, Seoyoung C, Landon, Joan E, Lee, Yvonne C
Publicado 2015

Did FDA Decisionmaking Affect Anti-Psychotic Drug Prescribing in Children?: A Time-Trend Analysis

por Wang, Bo, Franklin, Jessica M., Eddings, Wesley, Landon, Joan, Kesselheim, Aaron S.
Publicado 2016

The effect of federal and state off-label marketing investigations on drug prescribing: The case of olanzapine

por Wang, Bo, Studdert, David M., Sarpatwari, Ameet, Franklin, Jessica M., Landon, Joan, Kesselheim, Aaron S.
Publicado 2017

Patient characteristics associated with use of TNF vs interleukin inhibitors as first-line biologic treatment for psoriatic arthritis

por Jin, Yinzhu, Chen, Sarah K, Lee, Hemin, Landon, Joan E, Merola, Joseph F, Kim, Seoyoung C
Publicado 2021

Temporal Trends in Prescribing of Bone-Directed Therapies in the United States, 2009–2020

por Cromer, Sara, D’Silva, Kristin M, Yu, Elaine Wei-Yin, Landon, Joan, Desai, Rishi, Kim, Seoyoung C
Publicado 2021

Real-world patient characteristics and use of disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a cross-national study

por Ingrasciotta, Ylenia, Jin, Yinzhu, Foti, Saveria S., Landon, Joan E., Tari, Michele, Mattace-Raso, Francesco, Kim, Seoyoung C., Trifirò, Gianluca
Publicado 2022